Skip to content

A comparative study of Ayurvedic therapies and standard eye drops in patients with Primary Open Angle Glaucoma.

A randomised comparative clinical study of effectiveness of Pindi Nasya Chakshushya rasayana versus Antioxidant and Timolol in Kaphaja Adhimantha with special reference to Primary Open Angle Glaucoma - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108329
Enrollment
30
Registered
2026-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H401- Open-angle glaucoma

Interventions

None listed

Sponsors

Dr LAKSHMI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having features specific signs and symptoms of kaphaja adhimantha irrespective of sex, socio-economic status etc. 2. Patients with IOP less than 30 mmHg, including normotensive glaucoma. 3. Visual acuity better than 6 by 60.

Exclusion criteria

Exclusion criteria: 1.Patients below 20 years and above 60 years of age. 2. Patients suffering from systemic infectious diseases, pre-existing systemic and/or ocular morbidities that can cause diminution of vision and increased IOP or related to the central nervous system. 3. Patient with congenital, developmental, angle closure glaucoma, secondary and developmental glaucoma including exfoliative glaucoma, pigmentary glaucoma, lens- induced glaucoma, inflammatory glaucoma, end-stage glaucoma or optic atrophy. 4. Glaucoma involving other intraocular inflammation or chronic degenerative changes (RP). 5. Patients who have undergone any surgery intervention for glaucoma will be excluded. 6. All types of cataracts 7. Pregnancy and lactation 8. Contraindication for adverse reactions to Pindi and Nasya 9. Contraindications for Timolol maleate administration e.g. bronchial asthma, chronic obstructive pulmonary disease, heart disease, or in cases of adverse reactions to the same. 10. Any malignancy, uncontrolled diabetes, uncontrolled hypertension. 11. Evidence of any anterior segment pathology like conjunctivitis, keratitis, uveitis 12. Opaque ocular media as corneal opacities, vitreous opacities. 13. Conditions precluding accurate and repeated measurement of intraocular pressure e.g. mental illnesses, hemifacial spasm, uncooperative patients.

Design outcomes

Primary

MeasureTime frame
Reduction in IOP and improvement in clinical symptoms of kaphaja adhimanthaTimepoint: Baseline and after completion of treatment

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr LAKSHMI

Government Ayurvedic College and Hospital, Patna

umapandey.nipun@gmail.com9431646285

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026